Detalhe da pesquisa
1.
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
N Engl J Med
; 390(6): 497-509, 2024 02 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38324483
2.
MASH clinical trials and drugs pipeline: An impending Tsunami.
Hepatology
; 2024 Mar 19.
Artigo
Inglês
| MEDLINE | ID: mdl-38502810
3.
MASLD/MetALD and mortality in individuals with any cardio-metabolic risk factor: a population based study with 26.7 years of follow-up.
Hepatology
; 2024 May 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38739848
4.
Incidence of liver cancer in young adults according to the global burden of disease database 2019.
Hepatology
; 2024 Apr 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38598364
5.
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF).
Hepatology
; 79(1): 135-148, 2024 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37505221
6.
A global action agenda for turning the tide on fatty liver disease.
Hepatology
; 79(2): 502-523, 2024 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37540183
7.
The Global Burden of Alcohol-associated Cirrhosis and Cancer in Young and Middle-aged Adults.
Clin Gastroenterol Hepatol
; 2024 Feb 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38428708
8.
Degree of Discordance Between FIB-4 and Transient Elastography: An Application of Current Guidelines on General Population Cohort.
Clin Gastroenterol Hepatol
; 2024 Feb 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38428706
9.
Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies.
Clin Gastroenterol Hepatol
; 22(3): 488-498.e14, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-37775028
10.
From Shadows to Spotlight: Exploring the Escalating Burden of Alcohol-Associated Liver Disease and Alcohol Use Disorder in Young Women.
Am J Gastroenterol
; 119(5): 893-909, 2024 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38147513
11.
Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD-related cirrhosis.
Hepatology
; 77(2): 546-557, 2023 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35809234
12.
Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study.
Hepatology
; 78(6): 1858-1866, 2023 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37203233
13.
Examining the interim proposal for name change to steatotic liver disease in the US population.
Hepatology
; 77(5): 1712-1721, 2023 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36645228
14.
IL-31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASH.
Hepatology
; 77(1): 20-32, 2023 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35686937
15.
Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study.
Hepatology
; 78(4): 1223-1239, 2023 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37162151
16.
HCC EV ECG score: An extracellular vesicle-based protein assay for detection of early-stage hepatocellular carcinoma.
Hepatology
; 77(3): 774-788, 2023 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35908246
17.
Use of non-invasive diagnostic tools for metabolic dysfunction-associated steatohepatitis: A qualitative exploration of challenges and barriers.
Liver Int
; 2024 Apr 18.
Artigo
Inglês
| MEDLINE | ID: mdl-38634796
18.
Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis.
Liver Int
; 2024 Apr 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38573034
19.
Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis.
Dig Dis Sci
; 69(1): 289-297, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37968557
20.
A proposal from the liver forum for the management of comorbidities in non-alcoholic steatohepatitis therapeutic trials.
J Hepatol
; 79(3): 829-841, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37001695